Chief Residents of Radiation Oncology, Drs. Robert Den and Evan Wuthrick have been accepted to the highly competitive 2010 AACR/ASCO Workshop on Methods in Clinical Cancer Research held in Vail, CO in August 2010.
Dr. Robert Den's proposal: Phase I study of the combination of the histone deacetylase inhibitor, vorinostat, with hypofractionated radiation therapy prior to prostatectomy for high risk prostate cancer.
Dr. Evan Wuthrick's proposal: Pilot Study to Reduce the Severity of Gastrointestinal Toxicity Using Concurrent Linaclotide with Chemoradiotherapy in Pancreatic Adenocarcinoma.
This is a great achievement for Jefferson to have two participants in the same year!